A detailed history of Group One Trading, L.P. transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 78,935 shares of TMCI stock, worth $618,061. This represents 0.02% of its overall portfolio holdings.

Number of Shares
78,935
Previous 103,192 23.51%
Holding current value
$618,061
Previous $686,000 33.38%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.01 - $8.45 $121,527 - $204,971
-24,257 Reduced 23.51%
78,935 $457,000
Q2 2024

Aug 14, 2024

SELL
$4.17 - $12.62 $79,096 - $239,376
-18,968 Reduced 15.53%
103,192 $686,000
Q1 2024

May 10, 2024

SELL
$11.48 - $15.86 $50,466 - $69,720
-4,396 Reduced 3.47%
122,160 $1.59 Million
Q4 2023

Feb 14, 2024

BUY
$6.03 - $12.88 $763,132 - $1.63 Million
126,556 New
126,556 $1.61 Million

Others Institutions Holding TMCI

About TREACE MEDICAL CONCEPTS, INC.


  • Ticker TMCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,403,300
  • Market Cap $434M
  • Description
  • Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...
More about TMCI
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.